Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (201-210 of 354) with videos related to

Pageof 36
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2017
Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodiesJoyce K Hwang, Chong Wang, Zhou Du, et al.
British Journal of Haematology|December 18, 2012
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)Jeffrey I Zwicker, Howard A Liebman, Kenneth A Bauer, et al.
Pediatric Blood & Cancer|March 27, 2015
A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delaysAmaranto Suarez, Martha Piña, Diana X Nichols-Vinueza, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2005
tp53 mutant zebrafish develop malignant peripheral nerve sheath tumorsStéphane Berghmans, Ryan D Murphey, Erno Wienholds, et al.
Blood|September 4, 2004
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412Richard M Stone, Daniel J DeAngelo, Virginia Klimek, et al.
Pharmacogenomics|August 2, 2014
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemiaFrancesco Ceppi, Chloé Langlois-Pelletier, Vincent Gagné, et al.
Scientific Reports|January 22, 2020
Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized ImmunotherapyNicholas L Truex, Rebecca L Holden, Bin-You Wang, et al.
Cancer Cell|June 15, 2013
SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomasLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
JCI Insight|January 18, 2019
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancerJeffrey I Zwicker, Benjamin L Schlechter, Jack D Stopa, et al.
Genome Biology|October 21, 2020
High throughput single-cell detection of multiplex CRISPR-edited gene modificationsElisa Ten Hacken, Kendell Clement, Shuqiang Li, et al.
Pageof 36

Showing results (201-210 of 354) with videos related to

Sort By:
Pageof 36
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2017
Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodiesJoyce K Hwang, Chong Wang, Zhou Du, et al.
British Journal of Haematology|December 18, 2012
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)Jeffrey I Zwicker, Howard A Liebman, Kenneth A Bauer, et al.
Pediatric Blood & Cancer|March 27, 2015
A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delaysAmaranto Suarez, Martha Piña, Diana X Nichols-Vinueza, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2005
tp53 mutant zebrafish develop malignant peripheral nerve sheath tumorsStéphane Berghmans, Ryan D Murphey, Erno Wienholds, et al.
Blood|September 4, 2004
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412Richard M Stone, Daniel J DeAngelo, Virginia Klimek, et al.
Pharmacogenomics|August 2, 2014
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemiaFrancesco Ceppi, Chloé Langlois-Pelletier, Vincent Gagné, et al.
Scientific Reports|January 22, 2020
Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized ImmunotherapyNicholas L Truex, Rebecca L Holden, Bin-You Wang, et al.
Cancer Cell|June 15, 2013
SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomasLinfeng Chen, Stefano Monti, Przemyslaw Juszczynski, et al.
JCI Insight|January 18, 2019
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancerJeffrey I Zwicker, Benjamin L Schlechter, Jack D Stopa, et al.
Genome Biology|October 21, 2020
High throughput single-cell detection of multiplex CRISPR-edited gene modificationsElisa Ten Hacken, Kendell Clement, Shuqiang Li, et al.
Pageof 36